Clinical features and outcome in hospitalized heart failure in Japan (from the ATTEND Registry). - Wikidata - awgldk - TriplyDB

Clinical features and outcome in hospitalized heart failure in Japan (from the ATTEND Registry).

Clinical features and outcome in hospitalized heart failure in Japan (from the ATTEND Registry).

http://www.wikidata.org/entity/Q43481224

about

Designing phase 3 sepsis trials: application of learned experiences from critical care trials in acute heart failure Heart failure as a general pandemic in Asia Agents with vasodilator properties in acute heart failure: how to design successful trials Short-term outcomes after hospital discharge in patients admitted with heart failure in Abeokuta, Nigeria: data from the Abeokuta Heart Failure Registry.Pharmacological Treatment of Heart Failure with Preserved Ejection Fraction Designing effective drug and device development programs for hospitalized heart failure: a proposal for pretrial registries.Long-term effects and prognosis in acute heart failure treated with tolvaptan: the AVCMA trial The relationship between the number of cardiologists and clinical practice patterns in acute heart failure: a cross-sectional observational study.Regional and ethnic differences among patients with heart failure in Asia: the Asian sudden cardiac death in heart failure registry.The Efficacy and Safety of Tolvaptan in Patients with Hyponatremia: A Meta-Analysis of Randomized Controlled Trials.Persistent increase in cardiac troponin T at hospital discharge predicts repeat hospitalization in patients with acute decompensated heart failure.Arginine vasopressin antagonist tolvaptan in the treatment of heart failure: a meta-analysis of randomized controlled trials.Efficacy and Safety of 1-Hour Infusion of Recombinant Human Atrial Natriuretic Peptide in Patients With Acute Decompensated Heart Failure: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial Heart Failure Clinical Trials in East and Southeast Asia: Understanding the Importance and Defining the Next Steps.TSOC-HFrEF Registry: A Registry of Hospitalized Patients with Decompensated Systolic Heart Failure: Description of Population and Management A Retrospective Study of the Treatment Outcome of Drug Therapies used in Heart Failure Patients with Associated Co-morbidities in a Tertiary Care Hospital Randomized pilot trial comparing tolvaptan with furosemide on renal and neurohumoral effects in acute heart failure.Combination decongestion therapy in hospitalized heart failure: loop diuretics, mineralocorticoid receptor antagonists and vasopressin antagonists.Pathophysiology of cardiorenal syndrome in patients with heart failure: Potential therapeutic targets.Atrial Fibrillation in Patients Hospitalized With Heart Failure: Patient Characteristics and Outcomes From the HEARTS Registry.Clinical effectiveness of tolvaptan in patients with acute decompensated heart failure and renal failure: design and rationale of the AQUAMARINE study.Clinical presentation, management, in-hospital and 90-day outcomes of heart failure patients in Trivandrum, Kerala, India: the Trivandrum Heart Failure Registry.Incidence and predictors of ischemic stroke during hospitalization for congestive heart failure.Heart failure: preventing disease and death worldwide.Heart failure epidemiology and novel treatments in Japan: facts and numbers.Characteristics, management modalities and outcome in chronic systolic heart failure patients treated in tertiary care centers: results from the EVIdence based TreAtment in Heart Failure (EVITA-HF) registry.Mortality prediction using CHADS2/CHA2DS2-VASc/R2CHADS2 scores in systolic heart failure patients with or without atrial fibrillation.Novel risk stratification with time course assessment of in-hospital mortality in patients with acute heart failure.Good response to tolvaptan shortens hospitalization in patients with congestive heart failure.Rationale and Design of Low-dose Administration of Carperitide for Acute Heart Failure (LASCAR-AHF).Administration of tolvaptan with reduction of loop diuretics ameliorates congestion with improving renal dysfunction in patients with congestive heart failure and renal dysfunction.Efficacy and safety of the early use of V2 receptor antagonists in elderly patients with decompensated heart failure.Lung Ultrasound Findings Detected During Inpatient Echocardiography Are Common and Associated With Short- and Long-term Mortality.Impact of chronic kidney disease on the diuretic response of tolvaptan in acute decompensated heart failure.The relationship between the time until commencement of tolvaptan and the length of hospital stay in heart failure patients.Rationale and Design of the Double-Blind, Randomized, Placebo-Controlled Multicenter Trial on Efficacy of Early Initiation of Eplerenone Treatment in Patients with Acute Heart Failure (EARLIER).

P2860

Q26749027-D1CE0745-0D4F-4571-91D7-7DB35071035B Q26801810-81E1E237-B1F0-473A-B9B1-481620B0A885 Q28084239-41B36431-ACBA-4A56-83CD-EEF80C294A45 Q30850575-0B4F902D-E520-4AD1-B814-F07DF15FB5BF Q33885952-B6E195A5-0CD3-423A-B782-6C013A2D6EBB Q34162294-5471123A-A455-4979-9872-7A26EFC3D68A Q34570220-691D0FE0-A9B6-459B-88CE-3E600ABB05E2 Q34799832-01EE5EAF-CBE2-4CE8-A586-CDF085C70457 Q36097850-DEC475DA-1097-49A3-9607-0185A995797A Q36170197-9F0FFE1B-230E-484B-B6AE-EFD7DFDA4A61 Q36335733-60409717-D823-4656-BF2D-A838EB08AEC6 Q36511449-DF41A97D-77FB-4A91-AF34-F8CD11A05F09 Q36664047-B664F7CC-C259-41B4-8E0E-05E8C7AE2753 Q36968996-93ECE132-4C48-4AFD-8B6F-6BF26B03326B Q37131802-41D7E04F-5D05-4E6E-8D3D-9246B806D07F Q37132505-FFF8355D-5EA6-4374-A9C5-CD42F66B4B3A Q37352407-0F283EA7-8918-436A-9075-37A76925F51C Q38536675-DE54D222-2A07-4229-9942-8188B06A0155 Q38667232-BC208943-9E93-4647-88CA-9BF5A5B85A49 Q38737823-804A322E-FE3C-424B-B535-B9E66F61A2DB Q39220435-18449190-0268-4C48-8669-41F4048D8728 Q40283235-BB185AF5-0078-4010-B85D-39C34995A911 Q40685285-7E19FFE0-F201-45CF-9490-30BDC008F013 Q42199698-0C2387DC-5A53-447E-8288-49732923F2DC Q42374001-96CA0E1C-3530-4AA1-A2B6-24CCEBC8DC0B Q44887473-9AA7394F-1410-47CD-88FF-784E12E83E1F Q46829296-36BAC18F-1932-4613-88DA-191692B210D7 Q47131704-8978CD1A-0519-4FC2-AEBD-C7359630FFDE Q47219873-7ACEA229-4A8E-4568-ACCB-71EC98A2CF8D Q47664942-375D7322-D16D-4BEE-8104-8F7C36EC0715 Q48171811-CA8E4661-9645-4CA2-9282-02925282CBC2 Q48227566-19061106-F010-481C-94FA-47AF37364554 Q48368777-445A91F8-FDFA-47AA-9E6F-1E2F7F714456 Q49536270-F0DAD836-C19D-4C9D-AEC6-5808D9883580 Q50056832-D50CAB5E-C6E6-4B48-B1D4-5F1FC8303062 Q51019622-99062C97-E1BE-4665-BEA3-054F6B9BD29E

P2860

Clinical features and outcome in hospitalized heart failure in Japan (from the ATTEND Registry).

http://www.wikidata.org/entity/Q43481224

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Clinical features and outcome ...... an (from the ATTEND Registry).

@en

Clinical features and outcome in hospitalized heart failure in Japan

@nl

type

label

Clinical features and outcome ...... an (from the ATTEND Registry).

@en

Clinical features and outcome in hospitalized heart failure in Japan

@nl

prefLabel

Clinical features and outcome ...... an (from the ATTEND Registry).

@en

Clinical features and outcome in hospitalized heart failure in Japan

@nl

P1433

Q43481224-4CE7D5F1-04CD-4939-BB14-8306F46E7526

P1476

Q43481224-43F69B28-025E-4CAA-9B12-DBFBEEF5D570

P2093

Q43481224-1A2B137B-7DEC-4855-BF50-DFF3DF4CD591

Q43481224-26A21B19-2061-41D7-9CE0-46CB42F7C5F2

Q43481224-3C05A846-3A35-40AB-BF6F-1B557E2A6733

Q43481224-3F0288EE-E69A-4FBF-BD17-B9FC19033FED

Q43481224-4AF837B6-B60E-4311-AD31-7AA1CB849DCA

Q43481224-5BA5EB48-4B74-4856-A3C3-361E59573B7F

Q43481224-5CC84C3C-DEAA-4812-B374-7E7F408852D9

Q43481224-63EC9795-4DEA-4CCF-ABB2-ED42ECD3AC8A

Q43481224-67D02F64-C0D2-45CA-BCCD-16CADE869AF9

Q43481224-A2FF9597-46FB-4A1A-8D98-47E4A1AFF453

P304

Q43481224-BEFED754-5A64-408A-B5E8-06C762B0F812

P31

Q43481224-9BB12C80-A069-4E96-A358-4ED169DCBCE8

P356

Q43481224-C62E4EEC-FD1B-4D7E-B3BD-CEAF1F4402D4

P433

Q43481224-8B61122A-136F-405F-8D9F-77048C728E56

P478

Q43481224-FC64F2CA-A860-4A31-8E9A-F7D660D7ED48

P577

Q43481224-383DFCE4-3AE8-4491-95E5-18D1B68F4576

P698

Q43481224-06A35984-4B05-4AA0-95AC-93072165A67F

P921

Q43481224-AFD1A7F1-70E5-4F5E-A420-90102AAAEFD6

P356

CIRCJ.CJ-13-0187

P1433

Circulation Journal

P1476

Clinical features and outcome ...... an (from the ATTEND Registry).

@en

P2093

Dai Yumino

http://www.w3.org/2001/XMLSchema#string

Katsuya Kajimoto

http://www.w3.org/2001/XMLSchema#string

Koji Murai

http://www.w3.org/2001/XMLSchema#string

Kuniya Asai

http://www.w3.org/2001/XMLSchema#string

Kyoichi Mizuno

http://www.w3.org/2001/XMLSchema#string

Masayuki Mizuno

http://www.w3.org/2001/XMLSchema#string

Naoki Sato

http://www.w3.org/2001/XMLSchema#string

Ryo Muanakata

http://www.w3.org/2001/XMLSchema#string

TEND Investigators

http://www.w3.org/2001/XMLSchema#string

Takehiko Keida

http://www.w3.org/2001/XMLSchema#string

P304

944-951

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1253/CIRCJ.CJ-13-0187

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

77

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23502987

http://www.w3.org/2001/XMLSchema#string

P921

hospitalization